Shirota Y - Search Results

1

[Thymidylate synthase and dihydropyrimidine dehydrogenase gene expressions in colorectal cancer using the Danenberg tumor profile method].

Nagano H, Ichikawa W, Simizu M, Shirota Y, Nihei Z. Nagano H, et al. Among authors: shirota y. Gan To Kagaku Ryoho. 2004 Jun;31(6):889-92. Gan To Kagaku Ryoho. 2004. PMID: 15222106 Japanese.

2

Intratumoral dihydropyrimidine dehydrogenase messenger RNA level reflects tumor progression in human colorectal cancer.

Shirota Y, Ichikawa W, Uetake H, Yamada H, Nihei Z, Sugihara K. Shirota Y, et al. Ann Surg Oncol. 2002 Jul;9(6):599-603. doi: 10.1007/BF02573898. Ann Surg Oncol. 2002. PMID: 12095978

3

Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.

Ichikawa W, Uetake H, Shirota Y, Yamada H, Nishi N, Nihei Z, Sugihara K, Hirayama R. Ichikawa W, et al. Among authors: shirota y. Clin Cancer Res. 2003 Feb;9(2):786-91. Clin Cancer Res. 2003. PMID: 12576451

4

Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer.

Ichikawa W, Takahashi T, Suto K, Nihei Z, Shirota Y, Shimizu M, Sasaki Y, Hirayama R. Ichikawa W, et al. Among authors: shirota y. Int J Cancer. 2004 Dec 20;112(6):967-73. doi: 10.1002/ijc.20511. Int J Cancer. 2004. PMID: 15316940

5

Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1.

Ichikawa W, Takahashi T, Suto K, Shirota Y, Nihei Z, Shimizu M, Sasaki Y, Hirayama R. Ichikawa W, et al. Among authors: shirota y. Int J Cancer. 2006 Oct 15;119(8):1927-33. doi: 10.1002/ijc.22080. Int J Cancer. 2006. PMID: 16736497

6

[Dihydropyrimidine dehydrogenase gene expression in patients with hepatic metastases from colorectal cancer].

Shirota Y, Ichikawa W, Yamada H, Uetake H, Nihei Z, Sugihara K. Shirota Y, et al. Gan To Kagaku Ryoho. 1999 Oct;26(12):1729-31. Gan To Kagaku Ryoho. 1999. PMID: 10560382 Japanese.

7

Thymidylate synthase gene expression in primary colorectal cancer and metastatic sites.

Yamada H, Ichikawa W, Uetake H, Shirota Y, Nihei Z, Sugihara K, Hirayama R. Yamada H, et al. Among authors: shirota y. Clin Colorectal Cancer. 2001 Nov;1(3):169-73; discussion 174. doi: 10.3816/CCC.2001.n.017. Clin Colorectal Cancer. 2001. PMID: 12450430

8

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.

Ichikawa W, Uetake H, Shirota Y, Yamada H, Takahashi T, Nihei Z, Sugihara K, Sasaki Y, Hirayama R. Ichikawa W, et al. Among authors: shirota y. Br J Cancer. 2003 Oct 20;89(8):1486-92. doi: 10.1038/sj.bjc.6601335. Br J Cancer. 2003. PMID: 14562021 Free PMC article. Clinical Trial.

9

Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer.

Ichikawa W, Takahashi T, Suto K, Yamashita T, Nihei Z, Shirota Y, Shimizu M, Sasaki Y, Hirayama R. Ichikawa W, et al. Among authors: shirota y. Br J Cancer. 2004 Oct 4;91(7):1245-50. doi: 10.1038/sj.bjc.6602139. Br J Cancer. 2004. PMID: 15354215 Free PMC article. Clinical Trial.

10

[A case of nonresectable advanced gastric cancer responding to combined chemotherapy with 5'-DFUR, CDDP, and MMC].

Tohyama Y, Kojima K, Shirota Y, Yasuda S, Nakamura T, Nihei Z, Hirayama R, Mishima Y. Tohyama Y, et al. Among authors: shirota y. Gan To Kagaku Ryoho. 1996 Jun;23(7):933-6. Gan To Kagaku Ryoho. 1996. PMID: 8678546 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters